| Matthew J Shepard, MD | |
|
320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 | |
| (412) 359-6200 | |
| Not Available |
| Full Name | Matthew J Shepard |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 11 Years |
| Location | 320 E North Ave Ste 208, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790129146 | NPI | - | NPPES |
| 15161540 | Other | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD473509 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| St Clair Hospital | Pittsburgh, PA | Hospital |
| Canonsburg General Hospital | Canonsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
New research just published has highlighted how El Niño could be transporting and spreading waterborne diseases like cholera thousands of miles, across oceans, with significant impacts for public health.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.
› Verified 3 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
New research just published has highlighted how El Niño could be transporting and spreading waterborne diseases like cholera thousands of miles, across oceans, with significant impacts for public health.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew J Shepard, MD 320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 Ph: (412) 359-6200 | Matthew J Shepard, MD 320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 Ph: (412) 359-6200 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
New research just published has highlighted how El Niño could be transporting and spreading waterborne diseases like cholera thousands of miles, across oceans, with significant impacts for public health.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.
› Verified 3 days ago
Pascal Olivier Zinn, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5150 Centre Ave Ste 433, Pittsburgh, PA 15232 Phone: 412-647-7614 Fax: 412-623-4653 | |
Enyinna L Nwachuku, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St, Suite B-400, Pittsburgh, PA 15213 Phone: 412-647-6777 Fax: 412-647-6483 | |
David Zorub, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5200 Centre Ave, Suite 617, Pittsburgh, PA 15232 Phone: 412-623-2972 | |
David Kaufmann, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St, Suite 300, Pittsburgh, PA 15219 Phone: 412-471-4772 | |
Sean Polster, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Lothrop St Ste 521, Suite B400, Pittsburgh, PA 15213 Phone: 412-647-8186 | |
Dr. Ali Fadhil, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St Ste 311, Pittsburgh, PA 15219 Phone: 412-647-2304 | |
Daryl Pinion Fields Ii, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St Ste B-400, Pittsburgh, PA 15213 Phone: 320-224-2705 |